Walter; Goodson; Fosbinder, Journal of the American Chemical Society, 1945, vol. 67, p. 660
作者:Walter、Goodson、Fosbinder
DOI:——
日期:——
US2388025
申请人:——
公开号:——
公开(公告)日:——
SAJTKULOVA, F. G.;LAPKIN, I. I.;PROXOROVA, T. S., XIM.-FARMATS. ZH., 1986, 20, N 3, 319-320
作者:SAJTKULOVA, F. G.、LAPKIN, I. I.、PROXOROVA, T. S.
DOI:——
日期:——
AMOSOVA, S. V.;GOSTEVSKAYA, V. I.;GAVRILOVA, G. M.;ENIKEEVA, E. I.;TROFIM+, ZH. ORGAN. XIMII, 1984, 20, N 12, 2521-2526
作者:AMOSOVA, S. V.、GOSTEVSKAYA, V. I.、GAVRILOVA, G. M.、ENIKEEVA, E. I.、TROFIM+
DOI:——
日期:——
NK 1 ANTAGONISTS
申请人:OPKO Health, Inc.
公开号:US20180215729A1
公开(公告)日:2018-08-02
A compound having the general structure shown in Formula I:
or pharmaceutically acceptable salts and/or solvates thereof are useful in treating diseases or conditions mediated by NK
1
receptors, for example various physiological disorders, symptoms or diseases, including emesis, depression, anxiety and cough.